Close Menu

NEW YORK (GenomeWeb News) – Stemina Biomarker Discovery said this week that it has raised $1 million in angel investments to further develop its product for assessing drug toxicity in the developing human embryo.

Angel groups DaneVest Tech Fund Advisors, Phenomenelle Angels, and Wisconsin Investment Partners all contributed to the financing.

Stemina said that it plans to raise a total of $3 million in the financing round. In addition, the company said that it was recently awarded a $150,000 grant from the National Science Foundation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.